TCL Archive Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says. May 7, 2004
TCL Archive In Brief: Frederickson Resigns As NIH Director, Says He Wants “One More Career: As Scientist, Physician June 25, 1981
TCL Archive Dendreon Claims “Clear Hit” On Provenge, But Skeptics Await Data Presentation April 17, 2009
TCL Archive Funding Opportunities: NCI Offers Funds To Develop, Validate Mouse Models November 20, 1998
